Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Agenus Inc AGEN

Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >

Opinion & Analysis (NDAQ:AGEN)

Seven biotech names on the upswing: 2016 small-cap biotech watchlist update

The Life Sciences Report March 11, 2016

Bullboard Posts (NDAQ:AGEN)

Whew!

Back up to a buck pre-consolidation.   Remember the days of $4 and $5?  That's $80-$100, folks.  Long, long way to go...
zalmonella - 3 days ago

Agenus (AGEN) Q1 2024 Earnings Call Transcript

BREAKING NEWS: $AGEN Agenus (AGEN) Q1 2024 Earnings Call Transcript2024-05-07 17:45:24 ET Image source: The Motley Fool. Agenus (NASDAQ:...
whytestocks - May 7, 2024

Agenus Reports First Quarter 2024 Results

Just In: $AGEN Agenus Reports First Quarter 2024 Results$100M royalty financing agreement with Ligand announced, bringing in capital via...
whytestocks - May 7, 2024

No(w) Fun City?

Is there a short squeeze on?  No news, up 40% in a day. After the 20:1 consolidation, there were 21 million share outstanding an 2...
zalmonella - April 26, 2024

Top 2 Health Care Stocks Which Could Rescue Your Portfolio T

News; $AGEN Top 2 Health Care Stocks Which Could Rescue Your Portfolio This Month | BenzingaThe most oversold stocks in the health care...
whytestocks - April 23, 2024

No fun city

Great.  One April 13 i will have 250 shares of this worthless stock for which I've paid over the years a total of $10,400.  ...
zalmonella - April 8, 2024